Literature DB >> 22512267

Isothermal microcalorimetry: a novel method for real-time determination of antifungal susceptibility of Aspergillus species.

U Furustrand Tafin1, M Clauss, P M Hauser, J Bille, J F Meis, A Trampuz.   

Abstract

We evaluated microcalorimetry for real-time susceptibility testing of Aspergillus spp. based on growth-related heat production. The minimal heat inhibitory concentration (MHIC) for A. fumigatus ATCC 204305 was 1 mg/L for amphotericin B, 0.25 mg/L for voriconazole, 0.06 mg/L for posaconazole, 0.125 mg/L for caspofungin and 0.03 mg/L for anidulafungin. Agreement within two 2-fold dilutions between MHIC (determined by microcalorimetry) and MIC or MEC (determined by CLSI M38A) was 90% for amphotericin B, 100% for voriconazole, 90% for posaconazole and 70% for caspofungin. This proof-of-concept study demonstrated the potential of isothermal microcalorimetry for growth evaluation of Aspergillus spp. and real-time antifungal susceptibility testing.
© 2012 The Authors. Clinical Microbiology and Infection © 2012 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22512267     DOI: 10.1111/j.1469-0691.2012.03854.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  10 in total

Review 1.  [Areas of application of isothermal microcalorimetry in urology: an overview].

Authors:  G Bonkat; D Wirz; M Rieken; T C Gasser; A Bachmann; O Braissant
Journal:  Urologe A       Date:  2013-08       Impact factor: 0.639

2.  Activities of fluconazole, caspofungin, anidulafungin, and amphotericin B on planktonic and biofilm Candida species determined by microcalorimetry.

Authors:  Elena Maryka Maiolo; Ulrika Furustrand Tafin; Olivier Borens; Andrej Trampuz
Journal:  Antimicrob Agents Chemother       Date:  2014-02-24       Impact factor: 5.191

Review 3.  Next-generation antimicrobial susceptibility testing.

Authors:  Alex van Belkum; W Michael Dunne
Journal:  J Clin Microbiol       Date:  2013-03-13       Impact factor: 5.948

Review 4.  The molecular mechanism of azole resistance in Aspergillus fumigatus: from bedside to bench and back.

Authors:  Xiaolei Wei; Yuanwei Zhang; Ling Lu
Journal:  J Microbiol       Date:  2015-01-28       Impact factor: 3.422

Review 5.  Antifungal Susceptibility Testing: Current Approaches.

Authors:  Elizabeth L Berkow; Shawn R Lockhart; Luis Ostrosky-Zeichner
Journal:  Clin Microbiol Rev       Date:  2020-04-29       Impact factor: 26.132

6.  Microcalorimetry assay for rapid detection of voriconazole resistance in Aspergillus fumigatus.

Authors:  Ulrika Furustrand Tafin; Jacques F Meis; Andrej Trampuz
Journal:  Antimicrob Agents Chemother       Date:  2013-08-12       Impact factor: 5.191

7.  Promotion of quality standard of herbal medicine by constituent removing and adding.

Authors:  Dan Yan; Junxian Li; Yin Xiong; Congen Zhang; Jiaoyang Luo; Yumei Han; Ruiling Wang; Cheng Jin; Hong Qian; Jiangyu Li; Lingling Qiu; Cheng Peng; Yuling Lin; Xueai Song; Xiaohe Xiao
Journal:  Sci Rep       Date:  2014-01-13       Impact factor: 4.379

8.  Reduced ability to detect surface-related biofilm bacteria after antibiotic exposure under in vitro conditions.

Authors:  Christen Ravn; Ulrika Furustrand Tafin; Bertrand Bétrisey; Søren Overgaard; Andrej Trampuz
Journal:  Acta Orthop       Date:  2016-10-24       Impact factor: 3.717

9.  Comparative analysis of Staphylococcus aureus and Escherichia coli microcalorimetric growth.

Authors:  Dragos C Zaharia; Alexandru A Muntean; Mihnea G Popa; Alexandru T Steriade; Octavian Balint; Roxana Micut; Corneliu Iftene; Ioana Tofolean; Vlad T Popa; Cristian Baicus; Miron A Bogdan; Mircea I Popa
Journal:  BMC Microbiol       Date:  2013-07-24       Impact factor: 3.605

Review 10.  Antifungal susceptibility testing: current role from the clinical laboratory perspective.

Authors:  Brunella Posteraro; Riccardo Torelli; Elena De Carolis; Patrizia Posteraro; Maurizio Sanguinetti
Journal:  Mediterr J Hematol Infect Dis       Date:  2014-04-07       Impact factor: 2.576

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.